Clinical Trials Directory

Trials / Completed

CompletedNCT02935374

Effect of Antimicrobial Treatment of Acute Otitis Media on the Intestinal Microbiome in Children

Effect of Antimicrobial Treatment of Acute Otitis Media on the Intestinal Microbiome in Children: A Randomized Controlled Trial

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
73 (actual)
Sponsor
University of Oulu · Academic / Other
Sex
All
Age
6 Months – 7 Years
Healthy volunteers
Not accepted

Summary

This is a randomized, controlled trial studying the effects of various antimicrobial treatments on the intestinal microbiome of small children. The participating children with acute otitis media are treated wither with amoxicillin, amoxicillin-clavulanate or without antibiotics. The children with allergy to amoxicillin receive a course of macrolide and they will be monitored as a separate group. The main outcomes of this trial are the changes in the intestinal microbiome after the treatment.

Detailed description

Antimicrobial treatment of acute otitis media has been proven efficacious in children. It has been suggested that antimicrobial treatment makes a lot of harm to intestinal microbiome and may thus have effects on the child's health and wellbeing. However, data on these changes and their magnitude is scanty. This is a randomized, controlled trial studying the effects of various antimicrobial treatments on the intestinal microbiome of small children. The participating children with acute otitis media are treated wither with amoxicillin, amoxicillin-clavulanate or without antibiotics. The children with allergy to amoxicillin receive a course of macrolide and they will be monitored as a separate group. The main outcomes of this trial are the changes in the intestinal microbiome after the treatment.

Conditions

Interventions

TypeNameDescription
DRUGAmoxicillinThe children with acute otitis media will be treated with amoxixillin mixture, 100mg/ml, 40mg/kg/d, divided to two daily doses for 7 days.
DRUGAmoxicillin-Potassium ClavulanateThe children with acute otitis media will be treated with amoxixillin-clavulanate mixture, 80mg/ml, 45mg/kg/d, divided to two daily doses for 7 days.
DRUGMacrolideThe children with acute otitis media with a know allergy to amoxicillin or amoxicillin-clavulanate will be treated with macrolide and monitored separately

Timeline

Start date
2016-11-01
Primary completion
2020-03-01
Completion
2020-03-01
First posted
2016-10-17
Last updated
2022-08-11

Locations

1 site across 1 country: Finland

Source: ClinicalTrials.gov record NCT02935374. Inclusion in this directory is not an endorsement.